Predisposition of Wingless Subgroup Medulloblastoma for Primary Tumor Hemorrhage.
暂无分享,去创建一个
M. Kool | G. Kasprian | I. Slavc | T. Czech | C. Haberler | J. Gojo | D. Reisinger | Lisa Mayr | A. Azizi | A. Peyrl | M. Chocholous | L. Mayr
[1] H. Schild,et al. Imaging Biomarkers for Adult Medulloblastomas: Genetic Entities May Be Identified by Their MR Imaging Radiophenotype , 2017, American Journal of Neuroradiology.
[2] Sirintra Nakjang,et al. Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study , 2017, The Lancet. Oncology.
[3] Roland Eils,et al. The whole-genome landscape of medulloblastoma subtypes , 2017, Nature.
[4] A. Goldenberg,et al. Intertumoral Heterogeneity within Medulloblastoma Subgroups. , 2017, Cancer cell.
[5] E. Miele,et al. Anomalous vascularization in a Wnt medulloblastoma: a case report , 2016, BMC Neurology.
[6] M. Roussel,et al. Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype. , 2016, Cancer cell.
[7] M. Kool,et al. Risk stratification of childhood medulloblastoma in the molecular era: the current consensus , 2016, Acta Neuropathologica.
[8] J. Rutka,et al. Medulloblastoma: Tumor Biology and Relevance to Treatment and Prognosis Paradigm , 2016, Current Neurology and Neuroscience Reports.
[9] Naoki Kagawa,et al. Prognostic Value of Medulloblastoma Extent of Resection After Accounting for Molecular Subgroup: An Integrated Clinical and Molecular Analysis , 2016, The Lancet. Oncology.
[10] D. Ellison,et al. MR Imaging Characteristics of Wingless-Type–Subgroup Pediatric Medulloblastoma , 2015, American Journal of Neuroradiology.
[11] Y. Gezercan,et al. Fatal cerebellar hemorrhage as an initial presentation of medulloblastoma in a child , 2015, Journal of pediatric neurosciences.
[12] Jill S Barnholtz-Sloan,et al. Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011. , 2015, Neuro-oncology.
[13] Hideo Nakamura,et al. A patient with medulloblastoma in its early developmental stage. , 2014, Journal of neurosurgery. Pediatrics.
[14] P. Northcott,et al. Duration of the pre‐diagnostic interval in medulloblastoma is subgroup dependent , 2014, Pediatric blood & cancer.
[15] K. Yeom,et al. MRI Surrogates for Molecular Subgroups of Medulloblastoma , 2014, American Journal of Neuroradiology.
[16] Volker Hovestadt,et al. Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays , 2013, Acta Neuropathologica.
[17] Axel Benner,et al. FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] J. Mesirov,et al. Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] Hendrik Witt,et al. Medulloblastoma comprises four distinct molecular variants. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] Yiai Tong,et al. Subtypes of medulloblastoma have distinct developmental origins , 2010, Nature.
[21] Gentian Vyshka,et al. Sudden death due to medulloblastoma , 2010, BMJ Case Reports.
[22] Andrew P. McMahon,et al. Canonical Wnt Signaling Regulates Organ-Specific Assembly and Differentiation of CNS Vasculature , 2008, Science.
[23] Dirk Troost,et al. Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features , 2008, PloS one.
[24] E. Rushing,et al. Undiagnosed medulloblastoma presenting as fatal hemorrhage in a 14-year-old boy: case report and review of the literature , 2007, Child's Nervous System.
[25] D. Ellison,et al. Wnt/Wingless Pathway Activation and Chromosome 6 Loss Characterise a Distinct Molecular Sub-Group of Medulloblastomas Associated with a Favourable Prognosis , 2006, Cell cycle.
[26] T. Merchant,et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. , 2006, The Lancet. Oncology.
[27] T. Curran,et al. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] Claire L Weston,et al. beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] H. Clevers,et al. Wnt signalling in stem cells and cancer , 2005, Nature.
[30] M. Wolter,et al. Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors , 2001, International journal of cancer.
[31] E. Roach,et al. Nontraumatic Brain Hemorrhage in Children: Etiology and Presentation , 2000, Journal of child neurology.
[32] L. Becker,et al. Medulloblastoma: clinical presentation and management. Experience at the hospital for sick children, toronto, 1950-1980. , 1983, Journal of neurosurgery.
[33] D. Bruce,et al. Hemorrhagic brain tumors in pediatric patients. , 1981, Child's brain.